Published on in Vol 26 (2024)

This is a member publication of University of Strathclyde (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49309, first published .
Patients’ and Clinicians’ Perceptions of the Clinical Utility of Predictive Risk Models for Chemotherapy-Related Symptom Management: Qualitative Exploration Using Focus Groups and Interviews

Patients’ and Clinicians’ Perceptions of the Clinical Utility of Predictive Risk Models for Chemotherapy-Related Symptom Management: Qualitative Exploration Using Focus Groups and Interviews

Patients’ and Clinicians’ Perceptions of the Clinical Utility of Predictive Risk Models for Chemotherapy-Related Symptom Management: Qualitative Exploration Using Focus Groups and Interviews

Morven Miller   1 , BA (Hons), RGN, MSc, PhD ;   Lisa McCann   1 , MSc, PhD ;   Liane Lewis   2 , BSc, PhD ;   Christine Miaskowski   3 , RN, PhD ;   Emma Ream   4 , MSc, PhD ;   Andrew Darley   5 , BA(Mod), MSc, PhD ;   Jenny Harris   4 , MSc, GradCert, PhD ;   Grigorios Kotronoulas   6 , MSc, BSN, RN, PhD ;   Geir V Berg   7 , RN, MSc, PhD ;   Simone Lubowitzki   8 , MA, PhD ;   Jo Armes   4 , RGN, MSc, PhD ;   Elizabeth Patiraki   9 , RN, BSc, PhD ;   Eileen Furlong   10 , MMed Sc, PhD ;   Patricia Fox   10 , BNS, MA, PhD ;   Alexander Gaiger   8 , MD ;   Antonella Cardone   11 , MSc, MBA ;   Dawn Orr   12 , MSc, PhD ;   Adrian Flowerday   13 , BSc, CEng ;   Stylianos Katsaragakis   9 , BA, MSc, PhD ;   Simon Skene   14 , MSc, PhD ;   Margaret Moore   1 , BSc (Hons) ;   Paul McCrone   15 , BA (Hons), MSc, PhD ;   Nicosha De Souza   16 , MSc, PhD ;   Peter T Donnan   16 , BA, MSc, PhD ;   Roma Maguire   1 , RGN, BN, MSci, PhD

1 Computer & Information Sciences, University of Strathclyde, Glasgow, United Kingdom

2 Johnson and Johnson Medical, Norderstedt, Germany

3 University of California, San Francisco, CA, United States

4 School of Health Sciences, University of Surrey, Guildford, United Kingdom

5 School of Medicine, University College Dublin, Dublin, Ireland

6 School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, United Kingdom

7 Department of Health Sciences, Norwegian University of Science and Technology, Gjøvik, Norway

8 Department of Internal Medicine 1, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

9 School of Health Sciences, National and Kapodistrian University of Athens, Athens, Greece

10 School of Nursing, Midwifery and Health Systems, University College Dublin, Dublin, Ireland

11 European Cancer Patient Coalition, Brussels, Belgium

12 NHS 24, Glasgow, United Kingdom

13 Docobo Limited, Leatherhead, United Kingdom

14 Surrey Clinical Trials Unit, University of Surrey, Guildford, United Kingdom

15 Department of Health Services and Population Research, Institute of Psychiatry Psychology and Neuroscience, King’s College London, London, United Kingdom

16 Population Health and Genomics, Medical School, University of Dundee, Dundee, United Kingdom

Corresponding Author:

  • Roma Maguire, RGN, BN, MSci, PhD
  • Computer & Information Sciences
  • University of Strathclyde
  • 13.15 Livingston Tower
  • 26 Richmond Street
  • Glasgow, G1 1XQ
  • United Kingdom
  • Phone: 44 141 548 4101
  • Email: roma.maguire@strath.ac.uk